162 related articles for article (PubMed ID: 25490255)
1. Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.
Ishijima M; Nakayama H; Itonaga T; Tajima Y; Shiraishi S; Okubo M; Mikami R; Tokuuye K
Br J Radiol; 2015 Feb; 88(1046):20140596. PubMed ID: 25490255
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CTÂ Images.
Yamamoto T; Kadoya N; Sato Y; Matsushita H; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Morishita Y; Katagiri Y; Sato K; Ito K; Takeda K; Jingu K
Clin Lung Cancer; 2018 Jan; 19(1):e85-e90. PubMed ID: 28655592
[TBL] [Abstract][Full Text] [Related]
3. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
[TBL] [Abstract][Full Text] [Related]
4. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
Hayes JT; David EA; Qi L; Chen AM; Daly ME
Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
[TBL] [Abstract][Full Text] [Related]
5. Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.
Okubo M; Itonaga T; Saito T; Shiraishi S; Mikami R; Nakayama H; Sakurada A; Sugahara S; Koizumi K; Tokuuye K
Br J Radiol; 2017 May; 90(1073):20160508. PubMed ID: 28195507
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer.
Hayashi S; Tanaka H; Kajiura Y; Ohno Y; Hoshi H
Radiat Oncol; 2014 Jun; 9():138. PubMed ID: 24935216
[TBL] [Abstract][Full Text] [Related]
7. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema.
Kimura T; Togami T; Takashima H; Nishiyama Y; Ohkawa M; Nagata Y
Br J Radiol; 2012 Feb; 85(1010):135-41. PubMed ID: 21385918
[TBL] [Abstract][Full Text] [Related]
8. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy.
Zhou Z; Song X; Wu A; Liu H; Wu H; Wu Q; Liu Y; Li Y; Cai Y; Liang S
Sci Rep; 2017 Jun; 7(1):2748. PubMed ID: 28584268
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer.
Nakamura M; Nishimura H; Nakayama M; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Sasaki R
Br J Radiol; 2016 Dec; 89(1068):20160560. PubMed ID: 27805837
[TBL] [Abstract][Full Text] [Related]
11. Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy.
Sanuki N; Ono A; Komatsu E; Kamei N; Akamine S; Yamazaki T; Mizunoe S; Maeda T
J Radiat Res; 2012; 53(1):110-6. PubMed ID: 22302051
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
13. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
17. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy.
Yamashita H; Kobayashi-Shibata S; Terahara A; Okuma K; Haga A; Wakui R; Ohtomo K; Nakagawa K
Radiat Oncol; 2010 May; 5():32. PubMed ID: 20459699
[TBL] [Abstract][Full Text] [Related]
18. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
[TBL] [Abstract][Full Text] [Related]
19. Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy.
Ye L; Zhang Y; Li T; Zhang X; Shi S; Zhao Q; Zeng Z; He J
J Radiat Res; 2019 May; 60(3):371-379. PubMed ID: 30968939
[TBL] [Abstract][Full Text] [Related]
20. The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur?
Takenaka R; Shibamoto Y; Miyakawa A; Hashizume C; Baba F
Clin Lung Cancer; 2016 Sep; 17(5):406-411. PubMed ID: 26781347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]